The influence of socio-economic status on the fulfilment of Saint-Gallen recommendations for early-stage breast cancer

Socio-economic status (SES) is related to breast cancer diagnosis and prognosis. We study if SES is related to the adequacy of the treatment according to Saint Gallen consensus in Spanish women with incident breast cancer. Breast cancer cohort was assembled from incident cases from MCC-Spain and prospective followed-up afterwards. Participants were then classified according to the Saint-Gallen consensus in three categories (In Saint-Gallen, who received therapy accorded by Saint Gallen; Over Saint-Gallen, who received some additional therapy; or Under Saint-Gallen, who did not receive the complete therapy). Association between SES and Saint-Gallen fulfilment was analyzed using multinomial logistic regression, adjusting for clinicopathological and patient-related variables. 1115 patients in stages I and II were included. Women with university education were 58% more likely to receive over Saint-Gallen therapies (RRR = 1.68; 95%CI 0.84-3.33). In the simplified SES score, women with higher SES were over Saint-Gallen 52% more than those with lower SES (RRR = 1.52; 95%CI 0.88-2.64). Women with higher SES more often received over Saint-Gallen therapies. Further analyses are needed to understand the influence of these differences on the overall survival as well as its potential unwanted side effects.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2025-04-23
DOI
https://doi.org/10.1038/s41598-025-98469-z
Primary Topic
Global Cancer Incidence and Screening
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The influence of socio-economic status on the fulfilment of Saint-Gallen recommendations for early-stage breast cancer

Ana Molina‐Barceló, Amaia Aizpurua, Guillermo Fernández‐Tardón, Marina Pollán et al.
Scientific Reports
Global Cancer Incidence and Screening
article

The influence of socio-economic status on the fulfilment of Saint-Gallen recommendations for early-stage breast cancer

Ana Molina‐Barceló, Amaia Aizpurua, Guillermo Fernández‐Tardón, Marina Pollán, Tania Fernández‐Villa, Inés Gómez‐Acebo, Alba Marcos‐Delgado, Javier Llorca, Mónica Mirones, Beatriz Pérez‐Gómez, Jéssica Alonso-Molero, Eva Ardanáz, Ana Espinosa, Trinidad Dierssen‐Sotos, Marcela Guevara, Núria Aragonés, Mireia Obón‐Santacana, Gemma Castaño‐Vinyals, Pilar Amiano, Arantza Sanvisens, María Fernández-Ortiz, Juan L. Bayo, Manolis Kogevinas
article en

Abstract

Socio-economic status (SES) is related to breast cancer diagnosis and prognosis. We study if SES is related to the adequacy of the treatment according to Saint Gallen consensus in Spanish women with incident breast cancer. Breast cancer cohort was assembled from incident cases from MCC-Spain and prospective followed-up afterwards. Participants were then classified according to the Saint-Gallen consensus in three categories (In Saint-Gallen, who received therapy accorded by Saint Gallen; Over Saint-Gallen, who received some additional therapy; or Under Saint-Gallen, who did not receive the complete therapy). Association between SES and Saint-Gallen fulfilment was analyzed using multinomial logistic regression, adjusting for clinicopathological and patient-related variables. 1115 patients in stages I and II were included. Women with university education were 58% more likely to receive over Saint-Gallen therapies (RRR = 1.68; 95%CI 0.84-3.33). In the simplified SES score, women with higher SES were over Saint-Gallen 52% more than those with lower SES (RRR = 1.52; 95%CI 0.88-2.64). Women with higher SES more often received over Saint-Gallen therapies. Further analyses are needed to understand the influence of these differences on the overall survival as well as its potential unwanted side effects.

Scientific ReportsVol. 15(1)
Boston College (US), Universidad de Cantabria (ES), Universidad de Oviedo (ES), Universitat Pompeu Fabra (ES), Basque Government (ES), Instituto de Salud Carlos III (ES), Instituto de Salud Pública de Navarra (ES), Institut d'Investigació Biomédica de Bellvitge (ES), Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (ES), Ministry of Health (ES), Institut Català d'Oncologia (ES), Navarre Institute of Health Research (ES), Instituto de Investigación Marqués de Valdecilla (ES), Hospital Juan Ramón Jiménez (ES), Hospital Del Mar (ES), Municipal Institute for Medical Research (ES), Onkologikoa (ES), Barcelona Institute for Global Health (ES), Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES), Hospital del Mar Research Institute (ES), Universitat de Barcelona (ES), Universidad de León (ES)
Junta de Andalucía, Junta de Castilla y León, Fundación Marqués de Valdecilla, Instituto de Salud Carlos III
Gender equality
Openalex Percentile: Top 87%
Global Cancer Incidence and Screening
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.